Vivos (RDGL) Retained Earnings (2010 - 2025)
Vivos (RDGL) reported Retained Earnings of -$88.4 million for Q4 2025, down 3.59% on a YoY basis from -$91.7 million in Q4 2024, and down 1.23% sequentially from -$87.3 million in Q3 2025.
Vivos (RDGL) Retained Earnings (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Retained Earnings data on file, last reported at -$88.4 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings fell 3.59% year-over-year to -$88.4 million; the trailing twelve-month figure through Dec 2025 stood at -$88.4 million (down 3.59% YoY), and the FY2025 full-year result was -$88.4 million, down 3.59% from the prior year.
- Retained Earnings eased to -$88.4 million in Q4 2025, from -$87.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$74.8 million in Q1 2021 to a low of -$88.4 million in Q4 2025.
- A 5-year average of -$81.5 million and a median of -$81.0 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings decreased 2.43% in 2022 and retreated 4.02% in 2024, its largest moves.
- Tracing RDGL's Retained Earnings over 5 years: stood at -$77.1 million in 2021, then declined by 3.2% to -$79.6 million in 2022, then decreased by 3.64% to -$82.5 million in 2023, then dropped by 3.53% to -$85.4 million in 2024, then slipped by 3.59% to -$88.4 million in 2025.
- Business Quant data shows RDGL's Retained Earnings at -$88.4 million in Q4 2025, -$87.3 million in Q3 2025, and -$86.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.63 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -1.40 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 5.32 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | -88.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -88.43 Mn |
| Sep 30, 2025 | -87.35 Mn |
| Jun 30, 2025 | -86.84 Mn |
| Mar 31, 2025 | -86.20 Mn |
| Dec 31, 2024 | -85.36 Mn |
| Sep 30, 2024 | -84.34 Mn |
| Jun 30, 2024 | -83.51 Mn |
| Mar 31, 2024 | -83.01 Mn |
| Dec 31, 2023 | -82.45 Mn |
| Sep 30, 2023 | -81.37 Mn |
| Jun 30, 2023 | -80.71 Mn |
| Mar 31, 2023 | -79.80 Mn |
| Dec 31, 2022 | -79.56 Mn |
| Sep 30, 2022 | -78.85 Mn |
| Jun 30, 2022 | -78.57 Mn |
| Mar 31, 2022 | -77.79 Mn |
| Dec 31, 2021 | -77.09 Mn |
| Sep 30, 2021 | -76.91 Mn |
| Jun 30, 2021 | -76.71 Mn |
| Mar 31, 2021 | -74.85 Mn |